tiprankstipranks
Creightons PLC (GB:CRL)
LSE:CRL

Creightons (CRL) AI Stock Analysis

3 Followers

Top Page

GB:CRL

Creightons

(LSE:CRL)

Select Model
Select Model
Select Model
Outperform 72 (OpenAI - 5.2)
Rating:72Outperform
Price Target:
25.00 p
▼(-12.28% Downside)
Action:ReiteratedDate:11/25/25
Creightons' strong financial performance and attractive valuation are the primary drivers of its overall score. The robust balance sheet and low P/E ratio suggest financial stability and potential undervaluation. However, technical indicators show a bearish trend, and the decline in free cash flow growth is a risk that needs addressing.
Positive Factors
Balance sheet strength
Very low leverage and a ROE above 10% provide durable financial flexibility. This capital structure reduces refinancing and interest risks, supports consistent dividend and investment capacity, and enables the company to fund growth or weather demand shocks over months.
Negative Factors
Free cash flow decline
A near-60% drop in free cash flow growth is a persistent operational concern. Reduced FCF limits capacity to fund capex, dividends, debt paydown or M&A without tapping reserves, weakening the company's ability to execute strategic initiatives over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Balance sheet strength
Very low leverage and a ROE above 10% provide durable financial flexibility. This capital structure reduces refinancing and interest risks, supports consistent dividend and investment capacity, and enables the company to fund growth or weather demand shocks over months.
Read all positive factors

Creightons (CRL) vs. iShares MSCI United Kingdom ETF (EWC)

Creightons Business Overview & Revenue Model

Company Description
Creightons Plc, together with its subsidiaries, develops, manufactures, and markets toiletries and fragrances in the United Kingdom and internationally. It offers haircare, skincare, bath and body, wellbeing, and male grooming products. The compan...
How the Company Makes Money
Creightons makes money primarily by selling personal care and beauty products through two main routes: (1) manufacturing and supplying products for other brand owners/retailers (often referred to as contract manufacturing or private label), where ...

Creightons Financial Statement Overview

Summary
Creightons shows strong financial performance with improving revenue and profitability margins. The balance sheet is robust with low leverage, enhancing financial stability. However, the significant decline in free cash flow growth is a concern and needs attention.
Income Statement
75
Positive
Balance Sheet
80
Positive
Cash Flow
65
Positive
BreakdownTTMMar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Income Statement
Total Revenue54.21M54.07M53.19M58.57M61.16M61.60M
Gross Profit24.15M24.15M22.83M24.05M25.75M24.48M
EBITDA5.02M5.24M-1.21M2.69M5.34M6.94M
Net Income2.32M2.45M-3.53M514.00K3.11M4.33M
Balance Sheet
Total Assets39.67M38.14M36.14M45.54M47.85M33.55M
Cash, Cash Equivalents and Short-Term Investments3.35M3.66M3.14M1.65M840.00K6.56M
Total Debt2.94M3.25M3.92M7.28M8.22M3.96M
Total Liabilities14.72M13.91M14.09M20.06M22.17M13.46M
Stockholders Equity24.95M24.22M22.05M25.48M25.68M20.09M
Cash Flow
Free Cash Flow2.43M2.23M5.42M4.67M-508.00K4.17M
Operating Cash Flow2.94M2.91M6.03M5.81M1.22M5.41M
Investing Cash Flow-802.00K-662.00K-608.00K-2.64M-8.09M-1.07M
Financing Cash Flow-1.02M-1.73M-3.95M-2.35M1.16M-1.46M

Creightons Technical Analysis

Technical Analysis Sentiment
Negative
Last Price28.50
Price Trends
50DMA
26.57
Negative
100DMA
27.94
Negative
200DMA
30.38
Negative
Market Momentum
MACD
-1.25
Positive
RSI
24.47
Positive
STOCH
31.29
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:CRL, the sentiment is Negative. The current price of 28.5 is above the 20-day moving average (MA) of 24.48, above the 50-day MA of 26.57, and below the 200-day MA of 30.38, indicating a bearish trend. The MACD of -1.25 indicates Positive momentum. The RSI at 24.47 is Positive, neither overbought nor oversold. The STOCH value of 31.29 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:CRL.

Creightons Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
£157.54M15.5121.32%5.97%6.38%-10.55%
72
Outperform
£15.76M4.669.67%3.17%2.83%
66
Neutral
£242.29M3.9130.98%2.12%-0.89%1.30%
65
Neutral
£77.97M-8.91-0.12%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
54
Neutral
£329.72M14.34-2.16%4.82%-2.67%89.86%
42
Neutral
£24.18M-0.1597.34%-31.02%-4458.82%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:CRL
Creightons
23.00
-3.24
-12.35%
GB:MCB
McBride
145.60
11.89
8.89%
GB:PZC
PZ Cussons
78.60
9.11
13.12%
GB:VLG
Venture Life
64.00
25.00
64.10%
GB:W7L
Warpaint London
195.00
-138.45
-41.52%
GB:REVB
Revolution Beauty Group plc
2.78
-9.12
-76.64%

Creightons Corporate Events

Regulatory Filings and Compliance
Creightons Director’s Matched Share Deal Leaves Stake Unchanged
Neutral
Mar 27, 2026
Creightons plc reported that non-executive director and PDMR Paul Watts carried out a matched sale and repurchase of 160,000 ordinary shares in the company over two days on AIM. The transactions, executed at prices between 22.8p and 24.0p per shar...
Regulatory Filings and Compliance
Creightons Keeps Block Admission Balance Unchanged as No Options Exercised
Neutral
Mar 12, 2026
Creightons plc reported its latest six‑monthly block admission return for its employee share option scheme, confirming that no new shares were issued or allotted under the scheme between 12 September 2025 and 12 March 2026. As a result, the ...
Regulatory Filings and Compliance
Creightons Non-Executive Director Increases Stake with Share Purchase
Positive
Feb 5, 2026
Creightons plc has disclosed that non-executive director Paul Watts purchased 53,000 ordinary shares in the company at £0.278 per share on 4 February 2026, increasing his total holding to 160,000 shares. The director dealing, conducted on AIM...
Regulatory Filings and Compliance
Creightons Discloses Share Purchase by Associate of Non-Executive Director
Neutral
Jan 29, 2026
Creightons plc has disclosed that Steve Denison, a person closely associated with non-executive director Jemima Bird, purchased 52,994 ordinary shares in the company at a price of £0.2677 per share. The share acquisition, carried out on 28 Ja...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 25, 2025